<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Encounter Details</a></li><li><a href="#id2">Social History</a></li><li><a href="#id3">Last Filed Vital Signs</a></li><li><a href="#id4">Progress Notes</a></li><li><a href="#id5">Plan of Treatment</a></li><li><a href="#id6">Visit Diagnoses</a></li><li><a href="#id7">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter1" class="xRowNormal"><td>[REDACTED]  1:00 PM PDT</td><td ID="encounter1type">Office Visit</td><td><p>Kidney Specialists of [REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>Suite 310</p><p>[REDACTED], NV 89074-6391</p><p>[REDACTED]</p></td><td><p>[REDACTED], DO</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Stage 3a chronic kidney disease (CMS-HCC) (Primary Dx); <br/>Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC); <br/>Hyperkalemia; <br/>Vitamin D deficiency, not otherwise specified; <br/>Renal cell carcinoma &lt;Left side&gt; (CMS-HCC); <br/>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease; <br/>Chronic systolic congestive heart failure (CMS-HCC); <br/>Acquired absence of kidney</content></td></tr></tbody></table></div><h3><a name="id2" href="#toc">Social History</a></h3><div><table ID="sochist12"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td/><td ID="sochist12packsperday"/><td/><td/></tr><tr ID="sochist12smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex15"><td>Sex Assigned at Birth</td><td ID="BirthSex15Value">Not on file</td><td/></tr><tr ID="GenderIdentity13"><td>Gender Identity</td><td ID="GenderIdentity13Value">Not on file</td><td/></tr><tr ID="SexualOrientation14"><td>Sexual Orientation</td><td ID="SexualOrientation14Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id3" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">118</span>/<span class="content_span">76</span></td><td>[REDACTED] 12:59 PM PDT</td><td/></tr><tr ID="pulse_5794401540" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>86</td><td>[REDACTED] 12:59 PM PDT</td><td/></tr><tr ID="temp_" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>-</td><td>-</td><td/></tr><tr ID="resp_" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>-</td><td>-</td><td/></tr><tr ID="SpO2_" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>-</td><td>-</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5794401540" class="xRowNormal"><td class="xcellHeader">Weight</td><td>92.6 kg (204 lb 3.2 oz)</td><td>[REDACTED] 12:59 PM PDT</td><td/></tr><tr ID="height_5794401540" class="xRowAlt"><td class="xcellHeader">Height</td><td>170.2 cm (5' 7")</td><td>[REDACTED] 12:59 PM PDT</td><td/></tr><tr ID="bmi_5794401540" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>31.98</td><td>[REDACTED] 12:59 PM PDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id4" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MA - [REDACTED]  1:00 PM PDT: <content><span class="content_span">Summary: phq9</span><br/><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Phq9 score;0<br/><br/>Feeling down, depressed,  or hopeless:0<br/><br/>Thoughts that you would be better off dead or hurting yourself in some way:0</content><br/><span class="xLabel">Electronically signed by [REDACTED], MA at [REDACTED] 10:54 PM MDT</span><br/></content></li><li>[REDACTED], DO - [REDACTED]  1:00 PM PDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/> <br/>Reason for Visit:<br/>[REDACTED] is a [REDACTED]. male who is followed by Nephrology for AKI/CKD. First seen by KSOSN at HH 8/2021 for AKI <br/>Hx of renal carcinoma s/p left nephrectomy 2017 (Dr. Lasani), DM, HTN, CAD, HFrEF, pulm HTN RVSP 58, Afib<br/>8/2021 HH Afib RVR, new cardiomyopathy. Initial Cr 1.38 and discharge 1.6. Cardiac cath showed chronic total occlusion of RCA, proximal LAD and Lcirc disease. Viability study was done. Plan is for med mgmt and possible high risk PCI vs CABG in future. ICD was placed prior to discharge<br/> <br/>2/22 - No complaints. Reports recent cardiology visit, and good report. Has been off lokelma for about 1 month. Started entresto. SBP 120-130s<br/>5/22 - Had diagnostic cath for abnormal stress test. No stents needed. EF reportedly improved. Needed ablation for paroxysmal Afib. Complicated by right diaphragm freezing. Following with pulm now but no intervention needed. Denies urinary symptoms. Has not been following BP but thinks it's steady. <br/>8/22 - Diagnosed with sleep apnea, feels better on CPAP. Multiple attempts to get MRI, unable to get cardiac clearance to desert radiology. Labs were few days after his birthday, potassium 6. Notified by on call to stop entresto, lokelma cost him $320 but is taking daily. <br/>10/22 - Still unable to get MRI clearance from cardiology/PPM company. No urinary symptoms. Last cardiology visit went well. BP/A1c controlled<br/>1/23 - Averaged glucose in 200s over holidays with dietary indiscretion. Notes some LUTS but tolerable. <br/>4/23 - Asymptomatic. Has cardiology follow up upcoming. Trying to maintain low potassium diet. No urinary symptoms<br/>7/23 - Ran out of Veltassa 7/1, new co-pay unaffordable. Otherwise asymptomatic and DM/BP controlled. No urinary symptoms except frequent urination due to drinking lots of fluids + farxiga/torsemide<br/>10/23 - Wife present. No complaints. BP/DM controlled. No edema, no urinary symptoms. Veltassa remained unaffordable at specialty pharmacy<br/>8/24 - No complaints. Insurance no longer covering ozempic. Was helping. BP controlled. No urinary symptoms<br/> <br/>ASSESSMENT:<br/>CKD2, Risk factors include nephron loss, DM, HTN, CRS, AKI episode. UA [REDACTED]. Baseline cr 1.3-1.5 <br/>Renal carcinoma s/p left nephrectomy. R complex cyst<br/>Hypercalcemia, Hyperparathyroidism, Vit D def<br/>HTN, DM, CAD w multivessel dz, HFrEF, Afib<br/><br/> <br/>8/2021 RUS: 11.5cm right, left absent. mildly echogenic. septated appearing cystic structure 2.1cm. additional small rounded nodular focus at the margin of suspected cyst.<br/>11/2022 RUS: 11.8cm R kidney, left absent. Small cysts noted measuring up to 2.5cm on upper pole. These were present on CT chest 5/2022. PVR 40ml, prostate 5.3 x 4.6 x 3.8cm. Recommend follow up ultrasound [REDACTED]<br/>8/2023 RUS: 11.4cm, normal size/contour, diffuse increase in echogenicity multiple cysts<br/>6/2024 RUS: 12.6cm, no hydro or calculus. Multiple cysts - 1.5 cm(nonvascular) and 1.8cm. PVR 35.6cc, prostate 42.2mL<br/><br/>TTE 8/2021: Dilated LV, EF 20-25%, Unable to assess diastolic function, Mild MR, Mild TR<br/><br/>PLAN:<br/>GFR stable, monitor<br/>Cont low K diet. Veltassa samples previously provided, plan to use whenever potassium &gt;5.5<br/>PTH noted, monitor. Try to avoid hypercalcemia due to solitary kidney. Avoid calcium supplements.<br/>Monitor for LUTS<br/>DM per primary. On farxiga. Resume ozempic when able<br/>Monitor BP. On Entresto<br/>Torsemide, titrate prn<br/>Follow up [REDACTED] with repeat labs<br/><br/>Thank you for allowing Kidney Specialists of [REDACTED][REDACTED] (KSOSN) to participate in your care. <br/>If you have any questions, please do not hesitate to contact us. <br/><br/>[REDACTED], DO <br/>[REDACTED]<br/><br/>Vitals: <br/> [REDACTED] 1259 <br/>BP: 118/76 <br/>Pulse: 86 <br/>Weight: 204 lb 3.2 oz (92.6 kg) <br/>Height: 5' 7" (1.702 m) <br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Stage 3a chronic kidney disease (CMS-HCC) [REDACTED] <br/><br/>No past surgical history on file.<br/>Social History <br/><br/>Tobacco Use <br/> Smoking status: Former <br/> Smokeless tobacco: Never <br/>Substance Use Topics <br/> Alcohol use: Not Currently <br/> Drug use: Never <br/> <br/>Current Outpatient Medications <br/>Medication Instructions <br/> atorvastatin (LIPITOR) 80 MG tablet 1 tablet, Oral, Daily <br/> carvedilol (COREG) 25 MG tablet 1 tablet, Oral, 2 times daily <br/> Eliquis 5 mg, Oral, 2 times daily <br/> Entresto 24-26 MG per tablet 1 tablet, Oral, 2 times daily <br/> ezetimibe (ZETIA) 10 MG tablet 1 tablet, Oral, Daily <br/> Farxiga 10 mg, Oral, Daily <br/> glipiZIDE (GLUCOTROL) 5 MG tablet 1 tablet, Oral, Daily <br/> losartan (COZAAR) 25 mg, Oral, Daily <br/> metFORMIN (GLUCOPHAGE) 1000 MG tablet 1 tablet, Oral, 2 times daily <br/> torsemide (DEMADEX) 20 mg, Oral, Daily <br/><br/>Patient Active Problem List <br/>Diagnosis <br/> Acquired absence of kidney <br/> Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease <br/> Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC) <br/> Chronic systolic congestive heart failure (CMS-HCC) <br/> Renal cell carcinoma (CMS-HCC) <br/> Hemorrhoid <br/> Polyp of colon <br/> Hyperkalemia <br/> Other sex counseling <br/> Chronic kidney disease stage 2 <br/> Vitamin D deficiency <br/> <br/><br/>Results from last 6 months <br/>Lab Units [REDACTED]<br/>0452 <br/>SODIUM, SERUM/PLASMA mmol/L 142 <br/>POTASSIUM mmol/L 5.0 <br/>CHLORIDE mmol/L 107 <br/>CARBON DIOXIDE (CO2) mmol/L 26 <br/>BLOOD UREA NITROGEN (BUN) mg/dL 29* <br/>CREATININE mg/dL 1.32 <br/>GLUCOSE mg/dL 201* <br/>CALCIUM mg/dL 9.8 | 9.8 <br/>ALBUMIN g/dL 4.2 <br/>PHOSPHATE mg/dL 4.0 <br/><br/>Results from last 6 months <br/>Lab Units [REDACTED]<br/>0452 <br/>ALBUMIN/CREATININE, URINE mg/g creat 20 <br/><br/>Results from last 6 months <br/>Lab Units [REDACTED]<br/>0452 <br/>PTH INTACT pg/mL 77 <br/><br/>Results from last 6 months <br/>Lab Units [REDACTED]<br/>0452 <br/>HEMOGLOBIN (HGB) g/dL 14.4 <br/>HEMATROCRIT (HCT) % 43.9 <br/><br/>  <br/><br/>Physical Exam:<br/>NAD, well-developed<br/>Normal conjunctiva, EOMI, MMM<br/>No deformity of neck<br/>Normal S1, S2. No rub<br/>Unlabored respirations, symmetric chest rise<br/>Abd soft, no suprapubic tenderness<br/>No cyanosis, clubbing, edema<br/><br/>Orders Placed This Encounter <br/>Procedures <br/> Hemoglobin (HGB), Serum <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/> Renal Function Panel (RFP) <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/> Urinalysis, Complete, w/ Reflex to Culture <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/> Albumin, Random Urine with Creatinine <br/>  Standing Status:   Future <br/>  Number of Occurrences:   1 <br/>  Standing Expiration Date:   [REDACTED] <br/><br/>Return in about 6 months (around [REDACTED]) for with md. <br/><br/>Blood Pressure for this visit is 118/76. The follow up plan to address blood pressure is as above.  The patient should return for BP check in as above.  Body mass index is 31.98 kg/m². Follow up plan to address BMI is as above.<br/><br/>If this is a Telemedicine Visit, check below for visit type:<br/>[]Video <br/>[]Audio Only <br/><br/>Total approximated time of Telemedicine Visit:<br/>[]5 mins []10 mins []15 mins []20 mins []25 mins <br/>[]30 mins []35 mins []40 mins []45 mins []1 hour<br/><br/>Note:<br/>Please note that my documentation in this electronic health care record was produced using speech recognition software and, therefore, may contain errors related to this software.  These include, but are not limited to, grammar, punctuation, and spelling areas, as well as inclusion or exclusion of letters, words, or phrases that are not intended.   Please contact me for any clarification, questions, or concerns.  </content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:54 PM MDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id5" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter34" class="xRowNormal"><td>[REDACTED] 12:20 PM PDT</td><td ID="encounter34type">Office Visit</td><td><p>Kidney Specialists of [REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>Suite 310</p><p>[REDACTED][REDACTED]-6391</p><p>[REDACTED]</p></td><td><p>[REDACTED], DO</p><p>[REDACTED][REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure36"><td><span class="content_span">Hemoglobin (HGB), Serum</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3a chronic kidney disease (CMS-HCC)</p><p>Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC)</p><p>Hyperkalemia</p><p>Vitamin D deficiency, not otherwise specified</p><p>Renal cell carcinoma &lt;Left side&gt; (CMS-HCC)</p><p>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</p><p>Chronic systolic congestive heart failure (CMS-HCC)</p><p>Acquired absence of kidney</p></td><td ID="procedure36schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr><tr ID="procedure37"><td><span class="content_span">Renal Function Panel (RFP)</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3a chronic kidney disease (CMS-HCC)</p><p>Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC)</p><p>Hyperkalemia</p><p>Vitamin D deficiency, not otherwise specified</p><p>Renal cell carcinoma &lt;Left side&gt; (CMS-HCC)</p><p>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</p><p>Chronic systolic congestive heart failure (CMS-HCC)</p><p>Acquired absence of kidney</p></td><td ID="procedure37schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr><tr ID="procedure38"><td><span class="content_span">Urinalysis, Complete, w/ Reflex to Culture</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3a chronic kidney disease (CMS-HCC)</p><p>Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC)</p><p>Hyperkalemia</p><p>Vitamin D deficiency, not otherwise specified</p><p>Renal cell carcinoma &lt;Left side&gt; (CMS-HCC)</p><p>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</p><p>Chronic systolic congestive heart failure (CMS-HCC)</p><p>Acquired absence of kidney</p></td><td ID="procedure38schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr><tr ID="procedure39"><td><span class="content_span">Albumin, Random Urine with Creatinine</span></td><td>Lab</td><td>Routine</td><td><p>Stage 3a chronic kidney disease (CMS-HCC)</p><p>Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC)</p><p>Hyperkalemia</p><p>Vitamin D deficiency, not otherwise specified</p><p>Renal cell carcinoma &lt;Left side&gt; (CMS-HCC)</p><p>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</p><p>Chronic systolic congestive heart failure (CMS-HCC)</p><p>Acquired absence of kidney</p></td><td ID="procedure39schedule">Expected: [REDACTED], Expires: [REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id6" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx2" class="xRowNormal"><td><p><span class="content_span">Stage 3a chronic kidney disease (CMS-HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx3" class="xRowAlt"><td><p><span class="content_span">Type 2 diabetes mellitus with diabetic chronic kidney disease (CMS-HCC)</span></p></td></tr><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Hyperkalemia</span></p></td></tr><tr ID="vdx5" class="xRowAlt"><td><p><span class="content_span">Vitamin D deficiency, not otherwise specified</span></p></td></tr><tr ID="vdx6" class="xRowNormal"><td><p><span class="content_span">Renal cell carcinoma &lt;Left side&gt; (CMS-HCC)</span></p></td></tr><tr ID="vdx7" class="xRowAlt"><td><p><span class="content_span">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span></p></td></tr><tr ID="vdx8" class="xRowNormal"><td><p><span class="content_span">Chronic systolic congestive heart failure (CMS-HCC)</span></p></td></tr><tr ID="vdx9" class="xRowAlt"><td><p><span class="content_span">Acquired absence of kidney</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id7" href="#toc">Care Teams</a></h3><div><table ID="ct49"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED] </p><p>5C</p><p>[REDACTED], NV 89074</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td/><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>